Recurrent Synovial Sarcoma
3 clinical trials · Condition
◉ Watch Recurrent Synovial Sarcoma
| Record | Firm | Date |
|---|---|---|
| Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma (NCT03450122) | M.D. Anderson Cancer Center | 2018-09-13 |
| Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma (NCT02601209) | National Cancer Institute (NCI) | 2015-11-30 |
| Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma (NCT02452554) | Children's Oncology Group | 2015-10-12 |
Track Recurrent Synovial Sarcoma automatically
Every clearance here is in the API, with alerts when new ones post.